Helping Behavior: Clinical Trials

10 trials for Helping Behavior, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 10 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 310Completed 10

Follow Helping Behavior: new trials by email Literature Review of Helping Behavior trials Research Report on Helping Behavior

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)
Pergoveris®, GONAL-f®, Recombinant human chorionic gonadotrophin (r-hCG) - Infertility
Phase 3CompletedMerck KGaA, Darmstadt, Germany9392014-01-312017-08-24
"Effectiveness of a Brief Intervention for Substances Consumption Linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): A Randomized Control Trial in Chilean Primary Care."
ASSIST-linked brief intervention for hazardous and harmful substance use., Observation - Alcohol-Related Disorders, Substance-Related Disorders
Phase 3CompletedPontificia Universidad Catolica de Chile4002011-12-012013-10-09
PERgoveriS In Stratified Treatment for Assisted Reproductive Technique
Gonal-f®, Pergoveris®, Recombinant human chorionic gonadotropin (r-hCG) - Assisted Reproductive Techniques, Reproductive Technology, Assisted
Phase 3CompletedMerck KGaA, Darmstadt, Germany2022011-05-312021-05-28
Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031)
Corifollitropin alfa, recFSH (follitropin beta) - Infertility
Phase 3CompletedOrganon and Co3072010-06-022024-06-20
Efficacy and Safety Study of a Single Injection of SCH 900962 Versus Daily recFSH Injections in Women Undergoing Controlled Ovarian Stimulation (Study P06029)
SCH 900962 / Corifollitropin alfa / Org 36286, RecFSH / follitropin beta, Placebo for SCH 900962 - Infertility
Phase 3CompletedOrganon and Co14242010-06-012022-02-03
A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)
ganirelix, triptorelin - Controlled Ovarian Stimulation
Phase 3CompletedOrganon and Co2592007-05-012022-02-03
SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women
Gonalef® (Follitropin alfa), Purified pituitary gonadotropin (Fertinorm-P®) - Infertility, Ovulation Induction
Phase 3CompletedMerck KGaA, Darmstadt, Germany3002007-02-012013-12-27
A Prospective Study to Evaluate the Addition of Subcutaneous Recombinant Human-Luteinizing Hormone With Recombinant Human-Follicle Stimulating Hormone on Follicular Development in Women Undergoing Ovarian Stimulation for Assisted Reproductive Technologies
Recombinant Human-Luteinizing Hormone (Luveris) - Infertility, Ovarian Stimulation
Phase 3CompletedEMD Serono552004-09-012013-08-07
A Study Using Micronised Progesterone (Crinone® 8%) in the Luteal Phase Support of Women Undergoing in Vitro Fertilisation (IVF) and Embryo Transfer (ET)
Micronised Progesterone, Progesterone - Infertility
Phase 3CompletedMerck KGaA, Darmstadt, Germany2382004-05-012014-07-31
A Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, Ovidrel®) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET)
r-hCG, Urinary-hCG - Infertility
Phase 3CompletedMerck KGaA, Darmstadt, Germany2182003-12-012014-07-31

Narrower conditions

Infertility (7)  ·  Alcohol-Related Disorders (1)  ·  Polycystic Ovary Syndrome (1)  ·  Substance-Related Disorders (1)

Broader conditions

Behavior (10)  ·  Social Behavior (10)  ·  Genital Diseases (7)  ·  Urogenital Diseases (7)  ·  Adnexal Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Cysts (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases, Female (1)  ·  Gonadal Disorders (1)  ·  Mental Disorders (1)  ·  Neoplasms (1)  ·  Ovarian Cysts (1)

Interventions

Chorionic Gonadotropin (3)  ·  Ovidrel (3)  ·  follitropin alfa (3)  ·  follicle stimulating hormone, human, with HCG C-terminal peptide (2)  ·  follitropin beta (2)  ·  pergoveris (2)  ·  Luteinizing Hormone, beta Subunit (1)  ·  Observation (1)  ·  Profasi (1)  ·  Progesterone (1)  ·  Triptorelin Pamoate (1)  ·  Urofollitropin (1)  ·  ganirelix (1)

Sponsors

Merck KGaA, Darmstadt, Germany (5)  ·  Organon and Co (3)  ·  EMD Serono (1)  ·  Pontificia Universidad Catolica de Chile (1)

Countries

China (2)  ·  Germany (2)  ·  Chile (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Greece (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Russia (1)  ·  Slovakia (1)  ·  United Kingdom (1)

Top investigators

Huafei Li (2)  ·  Fernando Poblete, MD, MPH (1)  ·  Kimitoshi Takemura (1)  ·  Salvatore Longobardi, MD (1)

Results publications

PMID 22429192, PMID 26003273, PMID 26141305, PMID 26194884, PMID 26520396, PMID 26991902, PMID 27090863, PMID 27619773, PMID 28137754, PMID 29699333, PMID 37158538